Berita Valas

Australian Market Notably Lower

After ending with slight gains in the previous two sessions, the Australian stock market is notably lower on Tuesday, with the benchmark S&P/ASX 200 staying below the 7,100 level, despite the broadly positive cues from Wall Street overnight, with weakness across most sectors led by mining and technology stocks. Traders also cautiously await domestic inflation data due on Wednesday.
RTTNews | 1095 hari yang lalu
Canadian Stocks Turn In Mixed Performance; TSX Ends Marginally Up

Canadian Stocks Turn In Mixed Performance; TSX Ends Marginally Up

Canadian stocks turned in a mixed performance on Monday as investors stayed largely cautious, looking ahead to a slew of economic data, including reports on U.S. inflation, personal income and spending, and Canadian GDP report.
RTTNews | 1096 hari yang lalu
Dollar Climbs Higher On Interest Rate Bets

Dollar Climbs Higher On Interest Rate Bets

The U.S. dollar advanced against its major counterparts on Monday amid bets the Federal Reserve will keep interest rates higher for longer, and on concerns about the property market in China.
RTTNews | 1096 hari yang lalu
Swiss Market Ends Flat After Choppy Ride

Swiss Market Ends Flat After Choppy Ride

The Switzerland stock market recovered after a weak start Monday morning, but faltered after a brief spell in positive territory. However, with select counters attracting buyers past mid afternoon, regained lost ground and ended the day's session flat.
RTTNews | 1096 hari yang lalu
Euro Slides Against Majors

Euro Slides Against Majors

The euro fell against its major counterparts in the New York session on Monday.
RTTNews | 1096 hari yang lalu
Berita lainnya
Ardelyx Says Japan Approves Tenapanor For Hyperphosphatemia

Ardelyx Says Japan Approves Tenapanor For Hyperphosphatemia

Biopharmaceutical company Ardelyx, Inc. (ARDX) announced Monday that its collaboration partner in Japan, Kyowa Kirin Co., Ltd., has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for the New Drug Application (NDA) for tenapanor for the improvement of hyperphosphatemia in adult patients with chronic kidney disease (CKD) on dialysis. Tenapanor will be marketed with the brand name PHOZEVEL in Japan.
RTTNews | 1096 hari yang lalu
U.S. Dollar Climbs In Cautious Trade

U.S. Dollar Climbs In Cautious Trade

The U.S. dollar was higher in the European session on Monday, amid the Federal Reserve's stance of higher-for-longer interest rates and concerns about the property market in China.
RTTNews | 1096 hari yang lalu
Jasper Therapeutics Appoints Herb Cross As New CFO

Jasper Therapeutics Appoints Herb Cross As New CFO

Biotechnology company Jasper Therapeutics, Inc. (JSPR) announced Monday the appointment of Herb Cross, an experienced senior financial executive, as the company's Chief Financial Officer (CFO).
RTTNews | 1096 hari yang lalu
Appili Therapeutics Says FDA Approves LIKMEZ Metronidazole Oral Suspension

Appili Therapeutics Says FDA Approves LIKMEZ Metronidazole Oral Suspension

Biopharmaceutical company Appili Therapeutics, Inc. (APLI.TO, APLIF.PK) announced Monday that its manufacturing and commercialization partner, Saptalis Pharmaceuticals, LLC received approval from the U.S. Food and Drug Administration (FDA) for Metronidazole Oral Suspension 500mg/5mL (ATI-1501).
RTTNews | 1096 hari yang lalu
Bay Street Likely To Open Slightly Weak

Bay Street Likely To Open Slightly Weak

Slightly lower futures, and weakness in European markets point to a negative start for Canadian stocks on Monday. The mood in the market is likely to remain cautious with investors awaiting a slew of crucial economic data this week.
RTTNews | 1096 hari yang lalu

Tetap ikuti informasi terbaru!

Tambahkan Berita ke browser Anda

Extension Picture